Step Capital Management Pte. Ltd. Takes $2.05 Million Position in Docusign Inc. $DOCU

Step Capital Management Pte. Ltd. acquired a new position in Docusign Inc. (NASDAQ:DOCUFree Report) during the 4th quarter, HoldingsChannel reports. The fund acquired 30,000 shares of the company’s stock, valued at approximately $2,052,000. Docusign accounts for about 0.9% of Step Capital Management Pte. Ltd.’s investment portfolio, making the stock its 12th largest holding.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Centaurus Financial Inc. raised its position in Docusign by 2.6% during the 2nd quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock worth $420,000 after purchasing an additional 136 shares during the last quarter. Mitchell & Pahl Private Wealth LLC grew its position in shares of Docusign by 0.7% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company’s stock valued at $1,544,000 after buying an additional 149 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Docusign by 15.1% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,229 shares of the company’s stock valued at $89,000 after buying an additional 161 shares during the last quarter. Smartleaf Asset Management LLC increased its stake in shares of Docusign by 8.2% in the second quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock valued at $166,000 after buying an additional 165 shares during the period. Finally, Americana Partners LLC increased its stake in shares of Docusign by 3.3% in the third quarter. Americana Partners LLC now owns 5,467 shares of the company’s stock valued at $394,000 after buying an additional 176 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Docusign Price Performance

Shares of Docusign stock opened at $48.37 on Monday. The stock’s 50-day moving average is $47.40 and its 200 day moving average is $61.55. Docusign Inc. has a one year low of $40.16 and a one year high of $94.67. The firm has a market cap of $9.40 billion, a price-to-earnings ratio of 32.68, a PEG ratio of 1.88 and a beta of 0.99.

Docusign (NASDAQ:DOCUGet Free Report) last issued its earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The business had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. During the same period in the previous year, the company posted $0.86 earnings per share. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. On average, sell-side analysts expect that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign declared that its Board of Directors has initiated a stock repurchase program on Tuesday, March 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to buy up to 21% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s board believes its shares are undervalued.

Insider Buying and Selling

In other news, CEO Allan C. Thygesen sold 26,250 shares of the company’s stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $47.78, for a total transaction of $1,254,225.00. Following the transaction, the chief executive officer owned 152,237 shares in the company, valued at approximately $7,273,883.86. This represents a 14.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider James P. Shaughnessy sold 12,000 shares of the stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $46.83, for a total transaction of $561,960.00. Following the transaction, the insider directly owned 53,631 shares in the company, valued at $2,511,539.73. This trade represents a 18.28% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 97,423 shares of company stock worth $5,359,699 over the last ninety days. 1.01% of the stock is owned by company insiders.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Q3 results topped expectations — DOCU reported $1.01 EPS vs. $0.95 consensus and revenue of $836.9M, with revenue up ~7.8% YoY, signaling continued growth and margin improvement. MarketBeat DOCU summary
  • Positive Sentiment: Board authorized a $2.0 billion buyback (up to ~21% of shares) — a large repurchase program that management says indicates shares are undervalued and can support the share price over time. MarketBeat DOCU summary
  • Positive Sentiment: Institutional accumulation — several large funds (Norges Bank, Capital World, Arrowstreet, Marshall Wace, Woodline) materially increased positions in recent quarters, which can provide steadier demand for the shares. MarketBeat DOCU institutional holdings
  • Neutral Sentiment: Analyst mix remains split — consensus is a “Hold” with a $64.67 average target; broker price targets and ratings vary widely (from Underperform to Buy), leaving near‑term analyst-driven directional risk moderate. MarketBeat analyst coverage
  • Negative Sentiment: Significant insider selling this week — CEO Allan Thygesen sold 26,250 shares (avg ~$47.78) under a Rule 10b5‑1 plan. This is a sizable reduction in his stake and has likely weighed on sentiment. CEO Form 4
  • Negative Sentiment: CRO Paula Hansen and insider James P. Shaughnessy sold 6,000 and 12,000 shares respectively (each at ~\$46.8), both reported as executed under pre-arranged 10b5‑1 plans — multiple senior exits in one day can pressure sentiment despite plan disclosures. CRO Form 4
  • Negative Sentiment: Non‑executive director Mary Agnes Wilderotter sold 3,000 shares (~\$48.15), further adding to the week’s insider selling flow. Director Form 4

Analyst Upgrades and Downgrades

DOCU has been the topic of a number of recent analyst reports. Piper Sandler cut their price objective on Docusign from $75.00 to $52.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Citizens Jmp decreased their target price on shares of Docusign from $124.00 to $86.00 and set a “market outperform” rating for the company in a research report on Wednesday, March 18th. JPMorgan Chase & Co. lowered their price target on shares of Docusign from $78.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Morgan Stanley dropped their price target on shares of Docusign from $90.00 to $69.00 and set an “equal weight” rating on the stock in a research report on Wednesday, March 18th. Finally, Citigroup reduced their price objective on shares of Docusign from $120.00 to $99.00 and set a “buy” rating on the stock in a research note on Wednesday, March 18th. Five equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $64.67.

View Our Latest Report on DOCU

Docusign Profile

(Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Featured Articles

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCUFree Report).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.